Cytocybernetics is a Biotechnology which specializes in cellular electrophysiology
Cytocybernetics has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in March 2022.
Cytocybernetics's investors include National Science Foundation, University at Buffalo, 43North, NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR).
Cytocybernetics is headquartered in Buffalo, United States.
Cytocybernetics is a Biotechnology which specializes in cellular electrophysiology
Cytocybernetics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cytocybernetics — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/cytocybernetics. Accessed August 14, 2026.
VCBacked. (2022). Cytocybernetics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cytocybernetics
{{cite web |title=Cytocybernetics — Funding & Investors |url=https://www.vcbacked.co/company/cytocybernetics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated